Issue · November 8, 2026

The Brief

A woman kneeling by a rock, burying a small tin
Today's Ember

The early nineteen nineties, a dry cattle pasture in rural Zimbabwe. A young mother kneels beside a rock, folds a scrap of paper, pushes it into an old tin and buries it. On that paper are four dreams, and every one of them looks impossible.

Watch on The Morning Ember →

What's happening and what it means

U.S. disables cargo ship running Iran blockade; Iran says 2 tankers hit mines

CENTCOM said a U.S. aircraft fired on the stern of the St. Kitts-flagged cargo ship Huda in the Gulf of Oman Saturday after it left an Iranian port and ignored warnings, and announced a task force against Iran's land supply routes. Hours later Iran's Revolutionary Guard said two tankers hit mines near Hormuz. Oil fell 13% last week on deal talk; Saturday showed the U.S. still enforcing and Iran claiming the same, which keeps a floor under gasoline until a deal actually lifts the blockade. Full story →

Established
CENTCOM, 11/7: forces "disabled a commercial vessel in the Gulf of Oman, Nov. 7, after the ship's civilian crew ignored repeated warnings and attempted to violate the naval blockade against Iran multiple times." Since July 14: 147 vessels redirected, 5 disabled. Adm. Brad Cooper ordered Task Force Iron Gate, about 20 people in Tampa, to stop weapons and sanctioned goods crossing Iran's land borders and the Caspian. UKMTO: 18 nautical miles east of Khor Fakkan, UAE; crew status unknown. — CENTCOM release and X post, 11/7; UKMTO via Maritime Executive, 11/7
Attributed
IRGC press service, late 11/7: "Two ships that violated rules caught fire after hitting mines," one east of the strait and one inside it, after switching off navigation systems. CENTCOM: the blockade has blocked over $25 billion in Iranian crude exports. Trump, 11/6: "progress" toward a deal. — TASS and Anadolu, 11/8; Gulf News, 11/8; ABC News, 11/6
Unknown
No independent confirmation of the tanker fires: no names, flags, crew status, or who laid the mines. The Huda crew's condition. Whether Iron Gate adds enforcement or relabels existing sanctions work.

Israel's president taps Eisenkot, not Netanyahu, to form the next government

President Isaac Herzog told former army chief Gadi Eisenkot Saturday night he will receive the mandate Sunday, after 67 of 120 lawmakers recommended him and 46 backed Benjamin Netanyahu. He gets 28 days, extendable by 14. This is the first real opening in 17 years for an Israeli government not led by Netanyahu, Washington's partner in the Iran war. The catch: Eisenkot's bloc holds 48 seats, he has ruled out Arab parties, and he needs ultra-Orthodox parties he campaigned against to reach 61. Full story →

Established
Herzog's office, 11/7: both men informed Saturday evening; ceremony Sunday 5 p.m.; 67 recommendations for Eisenkot, 46 for Netanyahu, United Torah Judaism (7 seats) made none. Oct. 27 election: Eisenkot's alliance 48 seats, Netanyahu's bloc 53, Arab-led parties 19; 61 needed. If he fails, Herzog may tap another candidate; a third failure forces an election within 90 days. — President's Residence, as reported by Times of Israel and Al Jazeera, 11/7
Attributed
Eisenkot on X, 11/7: "now is the time for the formation of a national emergency government." Netanyahu, video, 11/7: called for a "national unity government" with his former partners and said of one relying on Arab parties, "Israel simply won't survive." Shas called reports it would tolerate Eisenkot "total fake news." — Times of Israel, 11/7; Al Jazeera, 11/7
Unknown
Whether UTJ or Shas will sit with a bloc that campaigned on mandatory Haredi service, or whether Eisenkot governs as a minority on Arab parties' outside votes. Netanyahu stays caretaker until a government is sworn in.

Mississippi Senate count drags on; GOP senators push to delay leadership vote

Democrat Scott Colom led Sen. Cindy Hyde-Smith by 2,574 votes with 97% counted Saturday; counties must certify by Nov. 13 and Mississippi has no recount. Sen. Ron Johnson circulated a letter to postpone Tuesday's Senate Republican leadership election after the party lost seven seats. Democrats already hold 54 seats to 44, so Mississippi and Alaska decide whether the majority is 54, 55 or 56, the margin that sets how many Democrats can defect on nominees and bills. The Republican fight is over whether John Thune keeps leading after the loss. Full story →

Established
AP count, 11/7: Colom 467,930, Hyde-Smith 465,356. NBC projection: Democrats 54, Republicans 44; Alaska: Peltola +637 at 74%, ranked-choice count Nov. 18 if no one tops 50%. Mississippi Secretary of State: no recount; mail ballots postmarked by Election Day count if received by Nov. 10. Sen. John Kennedy, 11/7: "I have signed Sen. Ron Johnson's letter to postpone Senate Republican leadership elections next Tuesday." — AP tallies via Yahoo News live blog, 11/7; Mississippi Secretary of State via ABC News, 11/6; Kennedy via Townhall, 11/7
Attributed
Hyde-Smith, 11/7: "We are not backing down. This election is not over." Colom's campaign manager estimates about 15,000 provisional ballots. Johnson: "We ought to have robust, soul-searching discussions in our conference!" No senator has challenged Thune. — WMC Action News 5, 11/7; ABC News, 11/6; Townhall, 11/7; Newsmax via Yahoo, 11/6
Unknown
How many provisional ballots exist and survive review. Whether Johnson has the five signatures to force a conference meeting (accounts differ) and whether Tuesday's vote slips.

Heart drug cut Lp(a) 78% but did not prevent heart attacks; Novartis drops it

Full results of the 8,350-patient Lp(a)HORIZON trial, presented Saturday at the American Heart Association meeting and published in NEJM, showed pelacarsen cut lipoprotein(a) 77.7% while major cardiac events ran 12.3% versus 12.1% on placebo over 4.7 years. Novartis dropped the program. About one in five people has high Lp(a), a mostly inherited risk factor that 2026 ACC/AHA guidelines say every adult should have measured once. If yours is high, no drug that lowers it has yet been shown to prevent heart attacks; statins and blood-pressure control remain what works. Full story →

Established
NEJM and NEJM Evidence, 11/7: 8,350 patients with prior cardiovascular events and Lp(a) of 70 mg/dL or higher; monthly 80 mg pelacarsen vs placebo; median follow-up 4.7 years; primary endpoint hazard ratio 1.02 (95% CI 0.90-1.15); Lp(a) down 77.7% at 12 months; drug-related adverse events 56.8% vs 18.0%. Novartis: development and managed-access programs discontinued. — NEJM via TCTMD, 11/7; Novartis topline statement 9/4
Attributed
Steven Nissen, Cleveland Clinic, presenter: one trial does not rule out benefit; Novartis's exit was "a good decision." Karol Watson, UCLA, discussant: despite strong genetics, "cardiovascular events didn't change." Donald Lloyd-Jones, Boston University: "we don't fully understand the biology here." — TCTMD and NPR, 11/7
Unknown
Whether Lp(a) is a cause or a marker, and whether Amgen's olpasiran and Lilly's lepodisiran, which cut it further and read out in coming years, succeed where pelacarsen failed.
How to read The Brief

Nobody's bias-free. Not the big outlets, not the "just the facts" newsletters, not us. So instead of promising clean news, we show our work. Every item carries three lines:

ESTABLISHED — backed by a primary document or independent confirmation.
ATTRIBUTED — somebody said it; we tell you exactly who and when. "The military reports a strike" is not "independent evidence confirms damage."
UNKNOWN — what's still unconfirmed. Five articles repeating one anonymous source is still one source.

One story. One brief. Every morning.

Get The Brief in your inbox before 8am.

Free. Unsubscribe any time.